Allergan plc (NYSE:AGN)

162.09
Delayed Data
As of Feb 23
 +2.69 / +1.69%
Today’s Change
156.00
Today|||52-Week Range
256.80
-0.91%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$53.5B

Company Description

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded on in 1984 and is headquartered in Dublin, Ireland.

Contact Information

Allergan Plc
Clonshaugh Business & Tech. Park
Dublin Dublin D17 E400
P:3538622617000
Investor Relations:

Employees

Shareholders

Other institutional47.38%
Mutual fund holders42.97%
Individual stakeholders0.29%

Top Executives

Brenton L. SaundersChairman, President & Chief Executive Officer
Matthew M. WalshChief Financial Officer & Executive VP
C. David NicholsonChief Research & Development Officer
Jonathon KellermanGlobal Chief Compliance Officer & Executive VP
William J. MeuryChief Commercial Officer